Toxicity Studies

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 8

TOXICITY STUDIES

Before any potential new medicine can be


administered to man its safety must be
investigated in animals in order to define
safe human doses.

Five general criteria for defining the high dose in a toxicology study:

 Maximum tolerated dose


 Limit dose
 Top dose based on saturation of exposure
 Maximum feasible/practical dose
 Dose providing a 50-fold margin of exposure
Maximum Tolerated Dose

• Highest dose that will be tolerated for the study duration


• A dose where target organ toxicity is likely to be observed but where the
dose is not so high that the study is jeopardized by morbidity or
mortality.
Limit dose

The limit dose defines the highest dose that should be used in the
absence of a demonstrable MTD. The limit dose is generally accepted as
1000mg/kg in both rodents and non-rodents.
Toxicokinetics and saturation of exposure

• Describes the systemic exposure achieved in animals and its relationship


to the dose, sex, species and the time course of the toxicity study.
• Blood samples are taken from animals on toxicity studies and the
plasma/serum or blood concentrations of the test item or its metabolites
are measured
• Where toxicokinetic data indicate that absorption limits exposure to the
test item or its metabolites, the lowest dose which achieves maximum
exposure should be used as the high dose in the absence of other dose
limiting constraints. This is often referred to as saturation of exposure.
Maximum Feasible Dose
• Practicalities, such as formulation, can mean the high dose is
limited by what is technically feasible based upon the maximum
possible concentration of the test item in the formulation.

Doses providing a 50-fold margin of exposure.


• Based on the group mean of the area under the curve (AUC)
values of the test item.
• Generally acceptable as the maximum
dose for acute and repeated dose toxicity
studies in any species.
Important Terms
 The Globally Harmonized System (GHS)

 Maximum Tolerated Dose (MTD)

 No Observable Effect Level (NOEL)

 Organization for Economic Cooperation and Development


(OECD)

 Committee for the Purpose of Control and Supervision of


Experiments on Animals (CPCSEA)

 Institutional Animal Ethics Committee (IAEC)

 Indian Council of Medical Reasearch(ICMR)


Acute Toxicity Sub-acute Toxicity Sub-chronic Chronic Exposure
(Repeated Dose)

Objectives To determine the To determine toxicity To establish (NOAEL), To evaluate the


Median Lethal Dose after repeated characterize dose- cumulative toxicity
(LD50), (NOEL), administration of the response relationships of chemicals and
(MTD)after a single test material and following repeated doses assess carcinogenic
dose administered. establish doses for sub- and predict dose for potential.
chronic studies. chronic exposure studies.

Duration 14 days after single dose 14 days 90 days 6-24 months

Species 2 species required. 2 species required. 2 species required. 2 species required.


Mice, rats, sometimes Mice, rats, rabbits, Rodents, dogs. Rodents, dogs.
rabbits or dogs. guinea pigs, dogs.
Dose 3 to 4 doses given by At least 3 doses given by As in sub-acute/ sub-
the same routes as the same routes as chronic toxicity
previous toxicity tests. previous toxicity tests; studies.
the lowest producing no
apparent toxicity and the
highest producing
toxicity but less than or
equal to 10% mortality.
Parameters 1. Mortality 1. Mortality 1. Mortality 1. Mortality
2. Clinical pathology 2. Signs of toxicity 2. Weight change 2. Pathology and
3. Gross necropsy 3. Pathology and 3. Signs of toxicity histopathology
4. Weight change histopathology 4. Clinical pathology 3. Weight change
5. Signs of toxicity 4. Weight change 5. Pathology and 4. Clinical
5. Clinical pathology histopathology pathology of all
animals (mortalities
and survivors)

You might also like